Team, Inc. TISI 深 沪
已收盘 01-09 16:00:00 美东时间
14.20
+0.290
+2.08%
华盛通- 最 高14.52
- 今 开13.86
- 成交量 1.12万股
- 最 低 13.53
- 昨 收 13.91
- 总市值 6388.44万
- 52周最高 24.25
- 市盈率 静 --
- 换手率 0.25%
- 52周最低 12.115
- 委 比 0.00%
- 总股本 449.89万
- 历史最高 480.90
- 量 比 0.86
- 振 幅 7.12%
- 历史最低 3.5301
- 每 手 1
- 风险率 2.35%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Akari Therapeutics to Present at the 2026 Biotech Showcase
Abizer Gaslightwala, President and CEO of Akari Therapeutics, will present at the 2026 Biotech Showcase on January 13, 2026, at 9:30 AM PST. His presentation will cover Akari's ADC platform, strategic priorities, and key milestones for 2026. Akari is developing next-generation ADCs with a unique RNA-splicing payload, PH1, targeting cancer cells. The lead candidate, AKTX-101, shows potential in preclinical studies and is expected to begin its firs...
01-08 14:15
Xometry Marketplace Accelerates Solutions for Complex Manufacturing Demands in 2026
Xometry announced platform enhancements to support advanced manufacturing demands, expanding its high-performance materials for aerospace, defense, and medical sectors. Eight new materials were added for FDM and SLA technologies, including PETG, Nylon 6 CF, and Accura SL 5530. Features like "Preferred Subprocess," looser tolerance options, and CMMC certification selection were introduced to enhance flexibility and control for buyers. Xometry cont...
01-08 14:05
Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology
Anavex Life Sciences Corp. has appointed Dr. Wolfgang Liedtke as Senior Vice President, Global Head of Neurology. With over 25 years of experience in CNS disease treatments, Dr. Liedtke brings extensive expertise in neurodegeneration, pain research, and translational neuroscience. He previously led 45 clinical trials at Regeneron and contributed to successful drug developments. Anavex focuses on innovative treatments for Alzheimer's, Parkinson's,...
01-08 12:30
夜读 | 黄仁勋CES“炸场秀”后的精彩问答来了！谈及关键临界点、护城河、马斯克以及亿万富翁税等
黄仁勋CES“炸场秀”后的精彩问答出炉！谈及关键临界点、护城河、马斯克以及亿万富翁税等>>
01-07 23:59
Abacus Global Management Launches Asset-Based Finance Strategy
Abacus Global Management launches an asset-based finance (ABF) strategy led by Monty Cook and Elena Plesco, former executives from Varde Partners and KKR. The strategy combines institutional origination expertise with Abacus's proprietary insurance analytics to target the $20 trillion asset-based finance market. Focused on stable cash flows and low volatility, the ABF strategy will invest in asset-backed opportunities, including consumer credit, ...
01-06 21:05
Galecto Announces Key Additions to Leadership Team
Galecto, a biotech company developing treatments for blood cancers, has appointed Sherwin Sattarzadeh as Chief Operating Officer and Dr. Becker Hewes as Chief Medical Officer. Both executives bring extensive experience in hematology/oncology drug development. The company is advancing DMR-001, a mutCALR-targeting monoclonal antibody, with an IND submission expected in mid-2026. Galecto's cash balance, including $285 million raised in November 2025...
01-06 13:00
HII Hosts Secretary of War Pete Hegseth at Newport News Shipbuilding
HII hosted Secretary of War Pete Hegseth at its Newport News Shipbuilding division as part of his "Arsenal of Freedom" tour. Hegseth praised shipbuilders for their vital role in national security and emphasized their contributions to naval capabilities. HII CEO Chris Kastner highlighted the company's efforts to boost shipbuilding efficiency through workforce expansion, technology adoption, and partnerships with other shipyards. The visit showcase...
01-06 00:30
Fortinet to Announce Fourth Quarter and Full Year 2025 Financial Results
Fortinet, a global leader in cybersecurity, announced it will host a conference call on February 5, 2026, at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss its fourth quarter and full year 2025 financial results. The call will be available live on Fortinet's investor relations website, with materials and a replay accessible afterward. Fortinet, known for its extensive cybersecurity portfolio, serves over half a million customers and c...
01-05 14:00
Treasure Global Regains Compliance with Nasdaq Bid Price Requirement
KUALA LUMPUR,马来西亚，2026年1月5日（GLOBE NEWSWIRE）——Treasure Global Inc.（纳斯达克股票代码：TGL）今天宣布，该公司于2025年12月23日收到纳斯达克的通知，确认其已恢复符合纳斯达克最低出价要求。纳斯达克已确认原定于2026年1月27日举行的听证会取消。Treasure Global的普通股将继续在纳斯达克市场交易。公司首席执行官表示，恢复合规后，公司将专注于执行战略计划并创造长期股东价值。Treasure Global是一家以马来西亚为基础的技术公司，旗下ZCITY超级应用程序整合了电子支付和客户忠诚度奖励，截至2025年6月已吸引超过270万名注册用户。
01-05 13:35
Hyperion DeFi Appoints Hyunsu Jung as Chief Executive Officer
Hyperion DeFi announced the appointment of Hyunsu Jung as CEO and Robert Rubenstein as General Counsel, alongside David Knox as CFO, to advance its strategic priorities. Jung, previously CIO, brings expertise in digital asset strategies, while Rubenstein offers decades of legal experience. The Company focuses on building a leading DeFi platform, Hyperliquid, with its native HYPE token, and developing the Optejet device for ophthalmic use.
01-05 13:00
